1. Myocardial infarction \< 4 weeks prior to randomisation (clinical definition)

2. Decompensated heart failure requiring inotropic support, invasive or non-invasive ventilation or Intra-aortic Balloon Pump/left ventricular assist device therapy \<72 hours prior to randomization

3. Sustained Ventricular Tachycardia/Ventricular Fibrillation or appropriate Implantable Cardioverter Defibrillator discharges \<72 hours prior to randomization

4. Valve disease requiring intervention

5. Contraindications to percutaneous coronary intervention

6. Age \<18 yrs

7. Estimated Glomerular Filtration Rate \< 25 ml/min, unless established on dialysis

8. Women who are pregnant

9. Previously enrolled in REVIVED-BCIS2 or current enrollment in other study that may affect REVIVED-BCIS2 outcome data

10. Life expectancy \< 1 yr due to non-cardiac pathology

Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure

What this study is about